NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expressionJan Wehkamp, Eduard F. Stange, Jürgen Harder et al.|Gut|2004Cited by 798
Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patientsK. J. Schmidt, Jürgen Büning, K Herrlinger et al.|Alimentary Pharmacology & Therapeutics|2012Cited by 84
Remission maintenance by tioguanine in chronic active Crohn's diseaseK Herrlinger, EF Stange, Peter Deibert et al.|Alimentary Pharmacology & Therapeutics|2003Cited by 47
ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative ColitisK Herrlinger, Elke Schaeffeler, Hülya Koç et al.|Clinical Pharmacology & Therapeutics|2011Cited by 46
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine AnaloguesK. J. Schmidt, Jürgen Büning, Niklas F. Müller et al.|Journal of Crohn s and Colitis|2015Cited by 23